Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2005
12/01/2005US20050267238 Polythiobis(alkylenephosphorus acids and esters), e.g., tetraethyl 3,3'-tetrathiobis(propylphosphonate) and bis(3-(bis(trimethylsilyl)phosphonyl)propyl) tetrasulfide; used as a coupling agent between an inorganic filler and an elastomer
12/01/2005US20050267212 Omega-3 fatty acids in the treatment of depression
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267112 intravenous or oral administration; hypotensive agents; enzyme inhibitors of cGMP-metabolizing phosphodiesterases
12/01/2005US20050267075 For cancer therapy, breast cancer, ovarian cancer, colorectal cancer, or non-small cell lung cancer in humans
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267032 Sulfone-containing prodrugs
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050266289 dialysis system or a two-phase reactor or a fuel cell containing a membrane comprised of a crosslinked copolymer; Exhibit extensive delocalization of negative charge; allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050263442 Collecting agent for sulphidic ores, the production and use thereof
12/01/2005DE102004022397A1 Chirale C2-symmetrische Biphenyle, deren Herstellung sowie Metallkomplexe enthaltend diese Liganden und deren Verwendung als Katalysatoren in chirogenen Synthesen Chiral C2-symmetric biphenyls, their preparation and metal complexes containing these ligands and their use as catalysts in synthesis chirogenic
12/01/2005CA2561819A1 Prodrugs of ion channel modulating compounds and uses thereof
11/2005
11/30/2005EP1599487A1 Phosphinic acid analogs of glutamate
11/30/2005EP1528957B1 Use of a collecting agent for sulphidic ores and method of its production
11/30/2005EP1224467B1 Protecting alkylating reagents used for quantifying homocysteine
11/30/2005EP1194436B1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005CN1702075A High-carried glyphosate salt stable liquid
11/30/2005CN1702074A Process for synthesizing dimethoate
11/30/2005CN1702073A Process for synthesizing O,O'-alkyl thiophosphoric acid
11/30/2005CN1702065A Fluorene-based compound and organic electroluminescent display device using the same
11/30/2005CN1229374C Substituted bisindolylmaleimides for inhibition of cell proliferation
11/30/2005CN1229368C Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
11/29/2005US6969756 Phosphorus element-containing crosslinking agents and flame retardant phosphorus element-containing epoxy resin compositions prepared therewith
11/29/2005US6969733 Photoinitiators
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/29/2005US6969694 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
11/29/2005US6969539 Vapor deposition of metal oxides, silicates and phosphates, and silicon dioxide
11/29/2005US6969528 novel phosphorus-containing dendrimers which are functionalized at the level of the inner layers and which comprise protonated tertiary amines as ends, have particularly advantageous properties as vectors for transferring nucleic acids
11/24/2005WO2005112101A2 Organometallic precursor compounds
11/24/2005WO2005111099A1 Ethylene copolymers
11/24/2005WO2005111050A2 Enantioselective phosphoramidite compounds and catalysts
11/24/2005WO2005110948A1 Method of reducing a functional group in an oxidised form
11/24/2005US20050261514 Process for the enantioselective hydrogenation of amino alcohols
11/24/2005US20050261374 Process for the preparation of prostaglandins and analogues thereof
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261264 Rare-earth ternary complex
11/24/2005US20050261253 Pharmacokinetics; bioavailability
11/24/2005US20050261252 LPA receptor agonists and antagonists and methods of use
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050258743 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof
11/24/2005DE4205306B4 Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden Acid amides, drugs with the same and method for the preparation of acid amides
11/24/2005CA2564954A1 Enantioselective phosphoramidite compounds and catalysts
11/24/2005CA2563928A1 Method of reducing a functional group in an oxidised form
11/23/2005EP1598408A1 A polymer for a photochromic compound matrix, and a matrix comprising the said polymer
11/23/2005EP1597244A1 Ethynyl derivatives serving as factor xa inhibitors
11/23/2005EP1597223A2 Hydroxyl compounds and compositions for cholesterol management and related uses
11/23/2005EP1597220A2 Phosphazenium salt mixtures containing hexakis(amino)diphosphazenium, tetrakis(amino)-phosphonium and polyaminophospazenium salts
11/23/2005EP1596808A2 L-dopa amide derivatives and uses thereof
11/23/2005EP1468112A4 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
11/23/2005CN1699386A Phosphinates compounds and their preparation process and use as stabilizer
11/23/2005CN1699385A Crystal form of adefovir dipivoxil
11/23/2005CN1699384A Cephems phosphate and preparation process and use thereof
11/23/2005CN1699383A Novel aryl fructose-1,6-bisphosphatase inhibitors
11/23/2005CN1699382A Sulfonic acid amine salt and method for producing the same
11/23/2005CN1699381A Hydroxy ethylidene diphosphonic acid with content of greater than or equal to 90 percent and process for making same
11/23/2005CN1699380A Amino trimethylene phosphonic acid with content of greater than or equal to 90 percent and process for making same
11/22/2005US6967256 Combining a terminal alkyne with a first transition metal complex to give a second transition metal complex; treating the second transition metal complex with a base
11/22/2005US6967252 Comprising a sterically hindered nitroxyl, hydroxylamine or hydrocarbyloxyamine moiety and a organohalogen or organophosphorus flame retardant moiety; polymer molding substrates; synergistic; nondripping; air pollution control
11/22/2005US6967193 phosphonate group-containing purine derivatives; for preventing type II diabetes
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108407A1 Cycloolefin phosphine ligands and their use in catalysis
11/17/2005WO2005108406A1 Bridged bi-aromatic catalysts, complexes, and method of using the same
11/17/2005WO2005108404A1 Heavy metal complex of ethynyl group-substituted fused heterocyclic compound, method for producing same, synthetic intermediate thereof, method for producing same, and organic electroluminescent device
11/17/2005WO2005108377A1 Pharmaceutical compositions
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005085262B1 Process for producing aminophosphonic acid derivative
11/17/2005US20050256345 Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols
11/17/2005US20050256342 Process for the carbonylation of ethylenically unsaturated compounds and bidentate diphosphine composition used in this process
11/17/2005US20050256334 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof
11/17/2005US20050256087 Phosphonic acid diester compounds
11/17/2005US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
11/17/2005US20050256034 Dioxolane analogs for improved inter-cellular delivery
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2562090A1 Bridged bi-aromatic catalysts, complexes, and methods of using the same
11/17/2005CA2559242A1 Cycloolefin phosphine ligands and their use in catalysis
11/16/2005EP1595888A1 Cycloolefin phosphine ligands and their use in catalysis
11/16/2005EP1595887A1 Chiral C2-symmetric biphenyls, preparation thereof as well as metal complexes containing these ligands and the use as catalysts in chirogene synthesis
11/16/2005EP1595886A1 Chiral diphosphinoditerpenes and their transition metals complexes
11/16/2005EP1595885A2 Chiral diphosphorus compounds and their transition metal complexes
11/16/2005EP1594550A2 Chelating agents with lipophilic carriers
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1405892B1 Red fluorescent material and composition containing the same
11/16/2005EP1392868A4 Method for the synthesis of dna sequences
11/16/2005EP1383777B1 Ligands for pnicogen chelate complexes with a metal of subgroup viii and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005EP1307466B1 Immunological adjuvant compounds
11/16/2005EP1283841B1 Reaction systems for making n-(phosphonomethyl)glycine compounds
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1227302C Chromium-free corrosion preventive and corrosion prevention method
11/16/2005CN1227256C Solvent-free method for preparing sterically hindered phosphoramidates
11/16/2005CN1227230C Prodrugs to NMDA receptor lagans
11/15/2005US6965047 cake of salt of organic or oxygen-containing inorganic acid or alkoxide reactant on filter element flowed through by solution of acid halide or alkyl halide reactant; insoluble halide salt formed remains on on the filter element
11/15/2005US6965040 Photogenerated reagents
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 554